1 investing lesson I have (re-)learned in 2022

Stock market corrections are often gold mines for investing lessons. The latest one is no different. 

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

RISK WARNING: should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice. The Motley Fool believes in building wealth through long-term investing and so we do not promote or encourage high-risk activities including day trading, CFDs, spread betting, cryptocurrencies, and forex. Where we promote an affiliate partner’s brokerage products, these are focused on the trading of readily releasable securities.

We might have expected 2022 to be a less challenging year than the last two. But we were in for a rude shock. The Russia-Ukraine war led to a stock market correction. And soon, the FTSE 100 index was back to the level of December 2021, when the Omicron-driven wobble happened. Many of my investment portfolio stocks are in the red now.

The one that stands out to me is the Russian miner and steel manufacturer Evraz. Not only is it in the red in my portfolio, trading in it has been halted recently. This only makes matters worse. 

Consider country risk

And this brings me to the investing lesson I have re-learned in 2022. That is, to always keep country risk in mind when buying stocks. This risk is associated with the political, economic, and business environment in which the company operates. 

I know it can look a bit confusing on the face of it, because after all, these stocks are listed on the London Stock Exchange. That is true, but so is the fact that a company can have multiple public listings in stock exchanges in different parts of the world. For example, AstraZeneca is listed both in the US and in the UK. As are the oil biggies BP and Shell.

The example of Evraz

But all companies have headquarters in a single country, or two at the very maximum. This is even if they have operations and markets in other parts of the world. Like in the case of Evraz, which has strong ties to Russia. 

It was founded in Moscow. And more than 50% of its revenues are from mines in the country. Even before the war, taxes on mining products were already on the rise, which threatened to impact its profits. And now of course it faces higher interest charges on any new domestic debt. It also faces blocks on selling commodities in the international markets. Trading in the stock has now halted in London too.

It is possible that Evraz had the highest dividend yield among all FTSE 100 companies till recently to compensate for higher country risk. It was also helped by the bull run in industrial metal prices seen in the recent past, which resulted in bumper profits for miners. But Evraz was far more rewarding even then than miners like Anglo American or Switzerland-based Glencore.

Applying the investing lesson

It is logical, though. Typically, mature economies and stable democracies have lower country risks than others. The downside to such stocks is that growth rates are not always as high as those in some emerging markets, like Russia.

So it is really about my priorities as an investor that should drive my investing decisions. I am not averse to risk, but it is a nice reminder to always be aware of it, as in this case. 

RISK WARNING: should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice. The Motley Fool believes in building wealth through long-term investing and so we do not promote or encourage high-risk activities including day trading, CFDs, spread betting, cryptocurrencies, and forex. Where we promote an affiliate partner’s brokerage products, these are focused on the trading of readily releasable securities.

Manika Premsingh owns Anglo American, AstraZeneca, BP, Evraz, Glencore and Royal Dutch Shell. The Motley Fool UK has no position in any of the shares mentioned. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Investing Articles

Publish Test

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut…

Read more »

Investing Articles

JP P-Press Update Test

Read more »

Investing Articles

JP Test as Author

Test content.

Read more »

Investing Articles

KM Test Post 2

Read more »

Investing Articles

JP Test PP Status

Test content. Test headline

Read more »

Investing Articles

KM Test Post

This is my content.

Read more »

Investing Articles

JP Tag Test

Read more »

Investing Articles

Testing testing one two three

Sample paragraph here, testing, test duplicate

Read more »